靜脈曲張治療市場規模、佔有率、成長分析（按類型、產品、最終用途和地區）- 產業預測（2025 年至 2032 年）

2022 年全球靜脈曲張治療市場價值為 13 億美元，預計將從 2023 年的 13.9 億美元成長到 2031 年的 23.3 億美元，預測期內（2024-2031 年）的複合年成長率為 6.7%。

全球靜脈曲張治療市場正經歷強勁成長，因為這種常見疾病的盛行率不斷上升，而人口老化、久坐不動的生活方式、肥胖和遺傳等因素都對這種疾病產生了影響。各種治療方法滿足了對有效治療方案的需求，尤其是靜脈內雷射消融、硬化療法和射頻消融等微創手術，這些療法具有減輕疼痛、加速恢復時間和減少疤痕等好處。技術進步提高了治療效果和患者滿意度，超音波導引泡沫硬化療法等創新技術越來越受歡迎。然而，挑戰依然存在，包括報銷問題和高昂的治療費用，這些可能會限制治療的可近性。此外，競爭格局正在加劇，需要在適應監管環境的同時不斷進行研發。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與約束

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 重大投資機會
• 市場生態系統
• 市場吸引力指數（2023年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球靜脈曲張治療市場規模（按類型和複合年成長率）（2024-2031）

• 市場概覽
• 靜脈消融
  • 靜脈雷射治療
  • 射頻消融術
• 注射硬化療法
• 手術結紮和剝離

全球靜脈曲張治療市場規模（依產品及複合年成長率）（2024 年至 2031 年）

• 市場概覽
• 消融設備
• 射頻消融術裝置
• 雷射消熔裝置
• 靜脈縫合產品

全球靜脈曲張治療市場規模（依最終用途及複合年成長率） （2024-2031 年）

• 市場概覽
• 醫院
• 門診手術中心
• 專科診所

靜脈曲張治療的全球市場規模及複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 按部門分類的公司佔有率分析
  • 收益年比比較（2021-2023年）

主要企業簡介

• Medtronic plc（Ireland）
• AngioDynamics, Inc.（USA）
• Teleflex Incorporated（USA）
• Boston Scientific Corporation（USA）
• Lumenis Ltd.（Israel）
• Quanta System SpA（Italy）
• Biolitec AG（Austria）
• Dornier MedTech GmbH（Germany）
• Sciton, Inc.（USA）
• Fotona doo（Slovenia）
• Viatris Inc.（USA）
• Merz Aesthetics（USA）
• SIGVARIS Group（Switzerland）
• Essity Aktiebolag（publ）（Sweden）
• F Care Systems NV（Belgium）
• VVT Medical（Israel）
• Alma Lasers（Israel）
• Energist Group（UK）.
• Eufoton srl（Italy）
• WONTECH Co., Ltd.（South Korea）

結論和建議

Global Varicose Veins Treatment Market size was valued at USD 1.3 billion in 2022 and is poised to grow from USD 1.39 billion in 2023 to USD 2.33 billion by 2031, growing at a CAGR of 6.7% during the forecast period (2024-2031).

The global varicose veins treatment market is experiencing robust growth, driven by the increasing prevalence of this common condition influenced by factors such as aging populations, sedentary lifestyles, obesity, and genetics. The demand for effective treatment options is being met by a range of modalities, particularly minimally invasive procedures like endovenous laser ablation, sclerotherapy, and radiofrequency ablation, which offer benefits like reduced pain, shorter recovery times, and less scarring. Technological advancements enhance treatment effectiveness and patient satisfaction, with innovative techniques such as ultrasound-guided foam sclerotherapy gaining traction. However, challenges remain, including reimbursement issues and high treatment costs, which may limit accessibility. Additionally, the competitive landscape is intensifying, necessitating ongoing research and development while navigating regulatory hurdles.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Varicose Veins Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Varicose Veins Treatment Market Segments Analysis

Global Varicose Veins Treatment Market is segmented by type, products, end use and region. Based on type, the market is segmented into endovenous ablation, injection sclerotherapy and surgical ligation & stripping. Based on products, the market is segmented into ablation devices, radiofrequency ablation devices, laser ablation devices and venous closure products. Based on end use, the market is segmented into hospitals, ambulatory surgical centers and specialty clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Varicose Veins Treatment Market

The expansion of the Global Varicose Veins Treatment market can be attributed to the heightened awareness and education surrounding varicose veins and the diverse treatment options available. Various public awareness campaigns, coupled with patient education initiatives and the dissemination of information through multiple platforms, have played a pivotal role in motivating individuals experiencing varicose veins to pursue suitable treatment solutions. This increased understanding of the condition has helped to eliminate stigma and misinformation, ultimately fostering a more proactive approach among patients in seeking effective care and management for their venous health issues.

Restraints in the Global Varicose Veins Treatment Market

The global varicose veins treatment market faces significant challenges due to regulatory requirements and the product approval processes that manufacturers must navigate. These stringent regulations can vary widely across different countries, creating a complex landscape that demands time and financial resources. As a result, obtaining the necessary approvals can delay the launch of new treatments and innovations, ultimately impacting the market's growth and the availability of advanced therapeutic options for patients. This regulatory burden can hinder manufacturers' ability to adapt and respond to emerging trends and advancements in varicose vein treatment strategies.

Market Trends of the Global Varicose Veins Treatment Market

The Global Varicose Veins Treatment market is increasingly witnessing a trend towards combination therapies as healthcare providers seek to enhance treatment efficacy and patient satisfaction. By integrating multiple modalities, such as endovenous ablation with sclerotherapy, practitioners can effectively address various facets of venous disease, improving overall outcomes. This approach acknowledges the complexities of varicose veins, leading to more tailored treatment plans and fostering patient confidence in their care. As awareness of varicose vein complications grows and patients demand more personalized treatment options, the market is expected to expand, driving innovation and collaborations among leading medical technology companies and healthcare providers.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Varicose Veins Treatment Market Size by Type & CAGR (2024-2031)

• Market Overview
• Endovenous Ablation
  • Endovenous Laser Therapy
  • Radiofrequency Ablation
• Injection Sclerotherapy
• Surgical Ligation & Stripping

Global Varicose Veins Treatment Market Size by Products & CAGR (2024-2031)

• Market Overview
• Ablation Devices
• Radiofrequency Ablation Devices
• Laser Ablation Devices
• Venous Closure Products

Global Varicose Veins Treatment Market Size by End Use & CAGR (2024-2031)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Global Varicose Veins Treatment Market Size & CAGR (2024-2031)

• North America (Type, Products, End Use)
  • US
  • Canada
• Europe (Type, Products, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Products, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Products, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Products, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lumenis Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quanta System S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biolitec AG (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dornier MedTech GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sciton, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fotona d.o.o. (Slovenia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merz Aesthetics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SIGVARIS Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Essity Aktiebolag (publ) (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F Care Systems NV (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VVT Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alma Lasers (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Energist Group (UK).
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eufoton s.r.l. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WONTECH Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations